Frank Rigo

20.2k citations
145 papers · 11.5k · 9 hit papers · h-index 49

Impact in

  • Genetics top 0.05%
    • Neurogenetic and Muscular Disorders Research
  • Neurology top 0.2%
    • Amyotrophic Lateral Sclerosis Research

Papers in

    • RNA Research and Splicing 52
    • RNA modifications and cancer 34
    • RNA and protein synthesis mechanisms 18
    • RNA Interference and Gene Delivery 12
    • Muscle Physiology and Disorders 11
    • Neurogenetic and Muscular Disorders Research 45

Frank Rigo

140 papers receiving 11.4k citations

Frank Rigo's Hit Papers

Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 2019 · 360 citations
3600+5+10Years since publication250500750

Peers

Frank Rigo
Comparison fields: 5 of 126
  • Genetics 3.7k
  • Neurology 2.2k
  • Molecular Biology 8.2k
  • Cancer Research 1.2k
  • Cellular and Molecular Neuroscience 1.5k
Replace Jernej Ule with:
Jernej Ule United Kingdom
Han‐Xiang Deng United States
Hynek Wichterle United States
Neil A. Shneider United States
Vincent Timmerman Belgium
Andreas Hermann Germany
Christopher E. Henderson France
Robert H. Baloh United States
Krystof S. Bankiewicz United States
Stanislav S. Zakharenko United States
Frank Rigo relative to Jernej Ule United Kingdom Jernej Ule's profile →
Citations per field
00.5×2.5×
Jernej Ule · 1×
Citations per year

Countries citing papers authored by Frank Rigo

Since Specialization
Citations

This map shows the geographic impact of Frank Rigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Rigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Rigo more than expected).

Fields of papers citing papers by Frank Rigo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Rigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Rigo. The network helps show where Frank Rigo may publish in the future.

Co-authors

The 25 scholars most cited alongside Frank Rigo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frank Rigo Line = papers co-authored together Frank Rigo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)
Hit paper breakdown →
2016884
2
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
Hit paper breakdown →
2016747
3
RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
Hit paper breakdown →
2013677
4
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Hit paper breakdown →
2011560
5
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Hit paper breakdown →
2010505
6
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Hit paper breakdown →
2013497
7 2011418
8
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Hit paper breakdown →
2017403
9
Towards a therapy for Angelman syndrome by targeting a long non-coding RNA
Hit paper breakdown →
2014382
10
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration
Hit paper breakdown →
2019360
11 2013317
12 2018285
13 2013256
14 2017225
15 2014218
16 2013177
17 2015152
18 2012132
19 2016127
20 2016125

About Frank Rigo

Frank Rigo is a scholar working on Molecular Biology, Genetics, Cellular and Molecular Neuroscience, Neurology and Genetics, having authored 145 papers that have together received 11.5k indexed citations. Recurring topics across this work include RNA Research and Splicing (52 papers), Neurogenetic and Muscular Disorders Research (45 papers), RNA modifications and cancer (34 papers), Amyotrophic Lateral Sclerosis Research (23 papers), Genetic Neurodegenerative Diseases (23 papers), RNA and protein synthesis mechanisms (18 papers), RNA Interference and Gene Delivery (12 papers) and Muscle Physiology and Disorders (11 papers). The work is most often cited by research in Genetics (3.7k citations), Neurology (2.2k citations), Molecular Biology (8.2k citations), Cancer Research (1.2k citations) and Cellular and Molecular Neuroscience (1.5k citations). Frank Rigo has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include C. Frank Bennett, Adrian R. Krainer, Yimin Hua, Gene Hung, Kentaro Sahashi, Seung Chun, Marco A. Passini, Amanda J. Ward, Paymaan Jafar‐Nejad and Harold G. Martinson. Their work appears in journals such as Nucleic Acids Research, Human Molecular Genetics, Proceedings of the National Academy of Sciences, Nucleic Acid Therapeutics and Science Translational Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact